诺华公司Novartis AG (NVS) 2008年年度报告「NYSE」.pdf

1、ANNUAL REPORT 2008NOVARTIS GROUP ANNUAL REPORT 2008101|GROUP REVIEW13|HE ALTHCARE PORTFOLIO57|CORPOR ATE CITIZENSHIP97|CORPOR ATE GOVERNANCE121|REMUNER ATION REPORT135|FINANCIAL REPORTContentsGROUP REVIEWOUR MISSIONWe want to discover,develop and successfully marketinnovative products to prevent and

2、 cure diseases,to easesuffering and to enhance the quality of life.We also want to provide a shareholder return that reflectsoutstanding performance and to adequately reward thosewho invest ideas and work in our company.CONTENTSGROUP REVIEWContents1Letter from Daniel Vasella5HEALTHCARE PORTFOLIOCont

3、ents13Emerging Markets16Pharmaceuticals23Research and Development35Vaccines and Diagnostics39Sandoz45Consumer Health51CORPORATE CITIZENSHIPContents57Commitment to Patients66Commitment to People and Communities77Commitment to the Environment83Commitment to Ethical Business Conduct90Independent Assura

4、nce Report95CORPORATE GOVERNANCEContents97Board of Directors110Executive Committee with Permanent Attendees116REMUNERATION REPORTContents121Remuneration Report122NOVARTIS GROUPFINANCIAL REPORTContents135Operating and Financial Review138Equity Strategy174Novartis Group Consolidated Financial Statemen

5、ts177Financial Statements of Novartis AG246Photo References254Key Dates 2009,Contact Informationand Forward-Looking Statements256NOVARTIS GROUP ANNUAL REPORT 20082GROUP OVERVIEWNovartis provides healthcare solutions that address the evolving needs of patients and societies worldwide.We offer a diver

6、sified portfolio to best meet these needs:innovative medicines,cost-saving generic pharmaceuticals,preventive vaccines and diagnostic tools,and consumer health products.KEY FIGURES CONTINUING OPERATIONS1(In USD millions,unless indicated otherwise)20082007Net sales41 45938 072Operating income28 9646